Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arizona Molecular Imaging Center (AMIC) is a premier diagnostic imaging facility and clinical research site based in Scottsdale, Arizona, specializing in advanced PET/CT imaging. The center is a recognized leader in oncological diagnostics, particularly for the early detection and staging of recurrent prostate cancer using innovative tracers such as Ga-68 PSMA and Axumin. Beyond its clinical practice, AMIC serves as a specialized site for clinical trials, partnering with biotechnology and pharmaceutical companies to evaluate novel molecular imaging agents. The facility provides high-resolution diagnostic data that supports precision medicine and personalized treatment planning for patients with cancer and neurological disorders. Led by experts in molecular imaging, AMIC remains at the forefront of adopting cutting-edge radiopharmaceutical technologies in the Southwest United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arizona Molecular Imaging Center.